People & Business :: Earnings/Finance
Johnson Matthey's fine chemicals division reports rise in operating profits
3:00 AM MST | November 22, 2012 | Deepti Ramesh
The fine chemicals division of Johnson Matthey recorded a 2.8% fall in sales in the fiscal first half ended 30 September 2012, compared with the corresponding period of the previous fiscal year, to £138 million ($220 million). Underlying operating profit for the fine chemicals division increased 14.5%, however, to £37.2 million. Sales from the division’s active pharmaceutical ingredient (API) manufacturing businesses, which comprise Macfarlan Smith (Edinburgh, United Kingdom) and Pharmaceutical Materials and Services (West Deptford, NJ), fell...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee